The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Stockwell Lynn since 2024.
This trader's CIK number is 1927032.
At the time of last reporting, Stockwell Lynn was the CEO and Executive COB of Drugs Made In America Acquisition Corp.. (stock ticker symbol DMAA).
Also see all insider trading activities at Drugs Made In America Acquisition Corp..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | BGXX | 0 | $0 | 1,000,000 | $360,000 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | DMAA | 400,000 | $0 | 5,698,363 | $0 | 0 | $0 |
2. Drugs Made In America Acquisition Corp. (DMAA)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-06-05 | BGXX | Sale | 1,000,000 | .36 | 360,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-01-29 | DMAA | Sale | 5,698,363 | .00 | 0 |
| 2025-01-29 | DMAA | Buy | 400,000 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Stockwell Lynn (CEO and Executive COB of Drugs Made In America Acquisition Corp. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.